Horizon Investment Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,097
Closed -$2.13M 127
2024
Q3
$2.13M Sell
4,097
-316
-7% -$169K 0.91% 38
2024
Q2
$2.39M Buy
4,413
+100
+2% +$52.9K 1.13% 33
2024
Q1
$2.24M Buy
4,313
+65
+2% +$32.3K 1.09% 37
2023
Q4
$2M Sell
4,248
-466
-10% -$215K 1.08% 34
2023
Q3
$2.05M Buy
4,714
+92
+2% +$41.7K 1.23% 29
2023
Q2
$2.05M Buy
4,622
+21
+0.5% +$9.69K 1.25% 29
2023
Q1
$2.12M Buy
+4,601
New +$2.19M 1.36% 24
2021
Q1
Sell
-6,771
Closed -$2.17M 113
2020
Q4
$2.17M Buy
6,771
+66
+1% +$20.3K 1.33% 26
2020
Q3
$1.8M Buy
6,705
+644
+11% +$173K 1.2% 30
2020
Q2
$1.59M Buy
+6,061
New +$1.62M 1.11% 31
2015
Q1
Sell
-1,779
Closed -$224K 141
2014
Q4
$224K Sell
1,779
-971
-35% -$120K 0.11% 122
2014
Q3
$329K Sell
2,750
-130
-5% -$14.9K 0.17% 88
2014
Q2
$310K Sell
2,880
-436
-13% -$44.9K 0.15% 99
2014
Q1
$334K Buy
3,316
+1,070
+48% +$96.8K 0.18% 86
2013
Q4
$208K Buy
+2,246
New +$200K 0.13% 107

Other funds holding ELV

Horizon Investment Services's ELV Position: Q4 2024 in Review

Horizon Investment Services sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 4,097 shares — an estimated $2.13M sold.

Horizon Investment Services first reported a position in ELV in Q4 2013 and held it in 15 quarters. The position peaked at $2.39M in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Horizon Investment Services reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Horizon Investment Services sold 4,097 Elevance Health shares in Q4 2024, an estimated $2.13M.
  • Horizon Investment Services first reported a position in Elevance Health in Q4 2013 and held it in 15 quarters.
  • Horizon Investment Services's Elevance Health position peaked at $2.39M in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Horizon Investment Services's 13F filing for Q4 2024, filed 12 Feb 2025.